Authors
Latest:
Successful treatment of bilateral diffuse Uveal melanocytic proliueration with plasmapheresisNonetheless,BDUMP remains a rare condition with fewer than 60 cases documented in literature.
Latest:
Key Takeaways on Managing Neovascular AMD and DMENathan Steinle, MD; Adrienne Scott, MD; Carl Regillo, MD, FACS, FASRS; and Prethy Rao, MD, MPH, share final thoughts on the changing treatment landscape of neovascular AMD and DME.
Latest:
Leaders in academic ophthalmology discuss AI for eye screeningArtificial intelligence in a primary care and clinic settings increases the likelihood of catching diabetic retinopathy in underinsured patients, resulting in increased successful referrals.
Latest:
Pearls for managing diabetic retinopathy in pediatric patientsInsulin pumps, digital technology and outcome analyses are useful tools
Latest:
Serious adverse reaction halts gene therapy for diabetic macular edemaDespite setbacks in DME, Adverum Biotechnologies said it will continue to develop ADVM-022 for wet AMD.
Latest:
Ultra-widefield imaging: A critical step in uveitis diagnosis and managementA multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Latest:
Key Takeaways on Managing Neovascular AMD and DMENathan Steinle, MD; Adrienne Scott, MD; Carl Regillo, MD, FACS, FASRS; and Prethy Rao, MD, MPH, share final thoughts on the changing treatment landscape of neovascular AMD and DME.
Latest:
Learnings from Real World Evidence of Faricimab in nAMD and DME: Part 2Arshad M. Khanani, MD, MA, FASRS, highlights the fluid resolution with faricimab and the need for loading doses, especially in high-needs switch patients with nAMD or DME.
Latest:
New VEGF trap for wet AMD takes aim at VEGF-C and VEGF-DReal-world patients often fail to achieve and retain the visual acuity results observed in clinical trials for anti–VEGF-A therapy. Broader therapeutic inhibition of additional angiogenic factors VEGF-C and VEGF-D could change that.
Latest:
Intravitreal pegcetacoplan for retinal tissue preservation in patients with GAGarg reported the 30-month data showing that patients receiving pegcetacoplan experienced an increasing treatment effect compared with sham (ie, a decrease in GA lesion area over time).
Latest:
Take-Home Points for the Treatment of AMD and DMEDavid A. Eichenbaum, MD, FASRS and Caroline Baumal, MD provide take-home messages to providers treating AMD and DME.
Latest:
How ophthalmology is pioneering the field of artificial intelligenceRetinal imaging tests are providing material to train and test decision support systems.
Latest:
Pediatric ophthalmologists target inherited retinal diseasesNew opportunities continue to develop in an evolving landscape.
Latest:
Case series finds floaters are a common side effect of SyfovreThe authors of a case series say silicone oil droplets from silicone used to lubricate the McKesson syringes is the most likely cause of the droplets presumed to cause the floaters.
Latest:
VEGF and beyond: therapeutic targeting in retinal vascular disordersPromoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.
Latest:
Optimizing Care For Patients With Retinal DisordersKey takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.
Latest:
Key Takeaways on Managing Neovascular AMD and DMENathan Steinle, MD; Adrienne Scott, MD; Carl Regillo, MD, FACS, FASRS; and Prethy Rao, MD, MPH, share final thoughts on the changing treatment landscape of neovascular AMD and DME.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Listening to the heart: Lessons from cardiology in remote monitoring and AIRather than speculating in a vacuum about the future of remote monitoring in ophthalmology, it is better to explore how other specialties in medicine adopted and integrated remote monitoring into their care plan frameworks.
Latest:
Dexamethasone rebuttal: Who should perform intravitreal injections?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Significance of periphery in diabetic retinopathy diagnosis and managementBeing able to visualize and evaluate the retinal periphery provides a better understanding of the disease status and supports a better treatment decision.
Latest:
2023: What awaits ophthalmology in the year aheadAs we approach the end of 2022, members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
Latest:
Big data: Driving opportunity for real-world evidenceEvidence-based medicine can lead to personalized care, better results for patients
Latest:
Practice perspective: Academic retinaA window into the world of academic retina practice today.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
